Is the oral formulation of fosfomycin supplied as a powder, and what is the recommended dosing for uncomplicated urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Fosfomycin Formulation and Dosing for Uncomplicated UTI

Yes, oral fosfomycin is supplied as a white powder in a sachet that must be dissolved in water before ingestion, and the standard dose for uncomplicated urinary tract infection (acute cystitis) in women is a single 3-gram dose. 1

Formulation Details

Oral fosfomycin (fosfomycin tromethamine) is a white powder administered as a sachet, to be dissolved in water and then swallowed. 2 Each sachet contains 5.631 grams of fosfomycin tromethamine (equivalent to 3 grams of fosfomycin base), along with inactive ingredients including mandarin flavor, orange flavor, saccharin, and sucrose. 1

Critical Administration Points:

  • Never take in dry form - must always be mixed with water before ingesting 1
  • Can be taken with or without food 1
  • Available in the United States and Europe 2

Dosing for Uncomplicated UTI

The recommended dosage for women 18 years and older with uncomplicated urinary tract infection (acute cystitis) is one sachet (3 grams) as a single dose. 1

Evidence Supporting Single-Dose Regimen:

The single 3-gram dose achieves:

  • Peak urinary concentrations of 1053-4415 mg/L within 4 hours 3
  • Urinary concentrations >128 mg/L (adequate to inhibit most uropathogens) maintained for 24-48 hours 3, 4
  • Clinical cure rates of 83-91% 5
  • Bacteriological eradication rates of 94.9% 6

Guideline Recommendations

Fosfomycin is recommended as a first-line agent for uncomplicated cystitis in women by multiple authoritative guidelines including IDSA, EAU, and NICE. 7, 5, 8, 3 The 2011 IDSA guidelines specifically state that fosfomycin trometamol (3 g in a single dose) is an appropriate choice for therapy due to minimal resistance and propensity for collateral damage, though it may have slightly inferior efficacy compared to standard short-course regimens. 7

Key Advantages:

  • Narrow antimicrobial spectrum (primarily E. coli, S. saprophyticus) 5
  • No collateral damage to microbiome 5
  • Currently low resistance rates (<1% in E. coli) 8
  • Excellent safety profile, including in pregnancy (Category B) 3
  • Single-dose regimen ensures compliance 3

Important Limitations

Fosfomycin is NOT appropriate for complicated UTI, pyelonephritis, or bacteremia. 2, 1 The oral formulation does not achieve adequate levels in tissue or bloodstream for these conditions. 2 If treating pyelonephritis or suspected bacteremia, oral fosfomycin should not be used as it fails to reach therapeutic levels in renal parenchyma or blood. 2

The FDA label explicitly states fosfomycin is indicated only for uncomplicated UTI (acute cystitis) in women and is not indicated for pyelonephritis or perinephric abscess. 1

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.